Overview

Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection

Status:
Not yet recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

the purpose of this study is to evaluate the efficacy and safety of pivmecillinam hydrochloride tablets in the treatment of uncomplicated urinary tract infection in China

Phase:

Phase 3

Details

Lead Sponsor:

Benova (Tianjin) Innovative medicine Research Co., Ltd.

Treatments:

Amdinocillin Pivoxil
Fosfomycin